Kubota Pharmaceutical Holdings Co Ltd

TSE:4596 (Japan)  
円 72.00 (+1.41%) Jun 13
At Loss
P/B:
1.73
Market Cap:
円 4.05B ($ 25.68M)
Enterprise V:
円 1.85B ($ 11.71M)
Volume:
51.10K
Avg Vol (2M):
298.88K
Also Trade In:
PE Ratio PS Ratio PB Ratio Price-to-FCF Market Cap
Current and historical daily PE Ratio for Kubota Pharmaceutical Holdings Co Ltd ( TSE:4596 ) from 2016 to Jun 14 2024. The price to earnings ratio is calculated by taking the current stock price and dividing it by the most recent trailing twelve-month earnings per share (EPS) number. The data is updated every 20 minutes during market hours. The PE ratio can be viewed as the number of years it takes for the company to earn back the price you pay for the stock. Therefore, lower-P/E stocks are more attractive than higher P/E stocks so long as the PE ratio is positive. Also for stocks with the same PE ratio, the one with faster growth business is more attractive. Kubota Pharmaceutical stock (TSE:4596) PE ratio as of Jun 14 2024 is 0. More Details

Kubota Pharmaceutical Holdings Co Ltd (TSE:4596) PE Ratio (TTM) Chart

To

Kubota Pharmaceutical Holdings Co Ltd (TSE:4596) PE Ratio (TTM) Historical Data

Total 1239
  • 1
  • 2
  • 3
  • 4
  • 5
  • 6
  • 14
Kubota Pharmaceutical PE Ratio (TTM) Historical Data
Date PE Ratio (TTM) Data Date PE Ratio (TTM) Data
2024-06-14 At Loss 2024-04-09 At Loss
2024-06-13 At Loss 2024-04-08 At Loss
2024-06-12 At Loss 2024-04-05 At Loss
2024-06-11 At Loss 2024-04-04 At Loss
2024-06-10 At Loss 2024-04-03 At Loss
2024-06-07 At Loss 2024-04-02 At Loss
2024-06-06 At Loss 2024-04-01 At Loss
2024-06-05 At Loss 2024-03-29 At Loss
2024-06-04 At Loss 2024-03-28 At Loss
2024-06-03 At Loss 2024-03-27 At Loss
2024-05-31 At Loss 2024-03-26 At Loss
2024-05-30 At Loss 2024-03-25 At Loss
2024-05-29 At Loss 2024-03-22 At Loss
2024-05-28 At Loss 2024-03-21 At Loss
2024-05-27 At Loss 2024-03-19 At Loss
2024-05-24 At Loss 2024-03-18 At Loss
2024-05-23 At Loss 2024-03-15 At Loss
2024-05-22 At Loss 2024-03-14 At Loss
2024-05-21 At Loss 2024-03-13 At Loss
2024-05-20 At Loss 2024-03-12 At Loss
2024-05-17 At Loss 2024-03-11 At Loss
2024-05-16 At Loss 2024-03-08 At Loss
2024-05-15 At Loss 2024-03-07 At Loss
2024-05-14 At Loss 2024-03-06 At Loss
2024-05-13 At Loss 2024-03-05 At Loss
2024-05-10 At Loss 2024-03-04 At Loss
2024-05-09 At Loss 2024-03-01 At Loss
2024-05-08 At Loss 2024-02-29 At Loss
2024-05-07 At Loss 2024-02-28 At Loss
2024-05-02 At Loss 2024-02-27 At Loss
2024-05-01 At Loss 2024-02-26 At Loss
2024-04-30 At Loss 2024-02-22 At Loss
2024-04-26 At Loss 2024-02-21 At Loss
2024-04-25 At Loss 2024-02-20 At Loss
2024-04-24 At Loss 2024-02-19 At Loss
2024-04-23 At Loss 2024-02-16 At Loss
2024-04-22 At Loss 2024-02-15 At Loss
2024-04-19 At Loss 2024-02-14 At Loss
2024-04-18 At Loss 2024-02-13 At Loss
2024-04-17 At Loss 2024-02-09 At Loss
2024-04-16 At Loss 2024-02-08 At Loss
2024-04-15 At Loss 2024-02-07 At Loss
2024-04-12 At Loss 2024-02-06 At Loss
2024-04-11 At Loss 2024-02-05 At Loss
2024-04-10 At Loss 2024-02-02 At Loss

Kubota Pharmaceutical Holdings Co Ltd (TSE:4596) PE Ratio (TTM) Comparison

Company Market Cap(Mil) PE Ratio (TTM)

Business Description

Business Description

Description
Kubota Pharmaceutical Holdings Co Ltd is a Japanese company providing portfolio of drugs and devices to preserve and restore millions of people. It identifies and develops therapeutics to treat the opthalmic disorder and operations incidental or related thereto. Its pipeline products include VCM-Emixustat HCI, Lanosterol and Optogenetics.